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Abstracts / International Journal of Surgery 36 (2016) S31eS132S1226 sphincters were inserted. 60% of patients had no complications. 1 patient
(20%) had ileoinguinal nerve irritation at 2 months. 1 sphincter failed
mechanically at 15 months. This was replaced and the patient remained
dry at 24months. 4 out of 5 patients (80%) were dry at latest follow up; the
remaining patient used 2-3 pads per day, an improvement from 6 pads
with ﬂooding preoperatively.
Conclusion: In our experience the use of AUS is an effective and safe
treatment for incontinence in women with intrinsic sphincter deﬁciency
or inappropriate urethral relaxation. We anticipate increasing future use of
female AUS in our practice.http://dx.doi.org/10.1016/j.ijsu.2016.08.449
0144: A COMPARISON OF TRANS-RECTAL ULTRASOUND (TRUS) MEA-
SUREMENT AND COMPUTER TOMOGRAPHY (CT) SCAN MEASUREMENT
OF PROSTATE SIZE
J. Filby*, O. Aboumarzouk, C. Bates. Royal Gwent Hospital, South Wales, UK.
Aim: To determine accuracy of calculated measurements of the prostate
gland utilising existing CT scans were concordant with TRUS measure-
ments provided by the same unit.
Background: When assessing risk of developing prostate cancer, the size
of the prostate is a key factor. TRUS biopsy is currently the gold standard
for diagnosing prostate cancer. It is possible to calculate prostate size by
extrapolation from CT scans of the pelvis.
Method: I carried out a Retrospective study of 1200 patients who under-
went TRUS biopsy in Royal Gwent Hospital. Patients who received a CT
scan within 1 year of TRUS biopsy. Approximate volume of the prostate
was calculated from the contours of the prostate on CT scan drawn by one
physician, who was unaware of the TRUS volume calculation, using axial
CT images.
Result: Of our sample population, 1 in 5 patients who underwent TRUS
biopsy and measurement had also received a CT scan within 1 year.
Comparing TRUS measurement with calculated CT measurement provided
a pearsons correlation co-efﬁcient of 0.93 indicating strong positive cor-
relation in this sample.
Conclusion: CT scan volumes andmeasurements correlate well with those
obtained by TRUS. To calculate risk of prostate cancer in patients CT images
can be used in the absence of TRUS measurement.http://dx.doi.org/10.1016/j.ijsu.2016.08.450
0267: POST-OPERATIVE BLOOD TESTS IN PATIENTS UNDERGOING URO-
LOGICAL SURGERY
P. Ravindra*, G. Lam, M.A.W. Miller. Northampton General Hospital,
Northampton, UK.
Most urological procedures have a low rate of complications. There is no
guidance in the literature on which patients should have post-operative
blood tests (POBT). We aimed to quantify their incidence and to establish if
patient management was consequently changed.
All adult patients undergoing Grade 1-3 urological procedures spending
1 night in hospital over 3 months was identiﬁed. Day 1 POBT incidence
was recorded. The consequence of abnormal results was investigated.
171 patients satisﬁed the inclusion criteria. Median length of stay: 1 day
(range 1-27). 94/171 patients underwent POBT, mainly FBC & U&E (92/94).
There was a signiﬁcant difference between pre-operative and post-oper-
ative sodium (average drop 2.02mmol/L [p¼0.0004]) but no signiﬁcant
difference with haemoglobin/creatinine (p>0.05). No patients received an
unplanned transfusion. One patient was diagnosed with new severe
hyponatraemia after a prolonged TURBT. The total cost of these tests was
£854.02 (annually £3416.08). >90% of results were reported after 11AM
thus delaying patient discharge.
There are a considerable number of POBT performed with no clinical
indication. The authors recommend a patient-speciﬁc approach based on
intra-operative judgement and clinical assessment. This would result insavings to the Trust both in terms of laboratory requirements and patient
ﬂow whilst maintaining safe practice.http://dx.doi.org/10.1016/j.ijsu.2016.08.451
0300: THE EFFICACY OF THULIUM LASER VAPO-ENUCLEATION IN PA-
TIENTS WITH LARGE VOLUME PROSTATES: OUTCOMES FROM A SINGLE
UK CENTRE
M.Wanis*, T. Seevagan, F. Alibeygi, M. Khan. University Hospitals of Leicester,
Leicester, UK.
Introduction: Laser transurethral prostatectomy (TURP) is increasingly
becoming the surgical treatment of choice for men with bladder outﬂow
obstruction (BOO) or acute urinary retention (AUR). However, its efﬁcacy
in men with larger prostates is less established. We determined the efﬁ-
cacy of thulium vapo-enucleation (ThuVEP) in patients presenting with
BOO+/-AUR and large volume prostates.
Method: From 2012-2015, 26 men with prostate volumes> /¼70cc
conﬁrmed on transrectal ultrasound underwent ThuVEP for BOO or AUR
by a single surgeon. Outcomes were measured using the International
Prostate Symptom Score (IPSS) and Quality of Life (QoL) score.
Result:Median follow-up was 16 months. 58% of patients had AUR and 42%
had BOO proven on urodynamics. Mean prostate volume was 113cc (range:
70cc-194cc) and mean PSA was 7.9ng/ml (range: 0.9e24ng/ml). Mean
maximum ﬂow rate was 9.4ml/s and post-void residual volume 309ml.
There was a signiﬁcant improvement in both IPSS and QoL scores post-
operatively (p<0001 for both). 93% of patients with AUR had a successful
trialwithout catheter post-operatively.Mean length of staywas1.6 days. No
patients required blood transfusion and there were no cases of urosepsis.
Conclusion: Our study demonstrates that ThuVEP is safe and effective in
men with BOO+/-AUR and large volume prostates.http://dx.doi.org/10.1016/j.ijsu.2016.08.452
0306: PROSTATE-SPECIFIC ANTIGEN TESTING IN THE COMMUNITY: IF
WE ARE DOING IT, LET'S DO IT RIGHT
D. Challoumas 1,*, M. Stoddart 1, J. Beaven 2, J. Phull 1, J. McFarlane 1. 1Royal
United Hospital Bath, Bath, UK; 2Beckington Family Practice, Beckington, UK.
Introduction: The present retrospective study aimed to assess the use of
PSA testing in primary care, identify potential problems and deﬁciencies,
and introduce simple strategies to improve practice.
Method: We searched the databases of two family practices in October
2015 and identiﬁed all patients who had a PSA test in the previous 6weeks.
We then conducted a detailed assessment of each PSA test based on the
doctors' documentation.
Result: A total of 153 patients with a recent PSA test were identiﬁed in the
two practices. In the majority of cases, the indication was either moni-
toring of known prostate cancer (39%) or lower urinary tract symptoms
(36%), while the indication was unclear in 7 patients (5%). Where appli-
cable, a UTI and vigorous exercise/sexual activity within 48 hours before
the test were excluded in 34% and 7% of cases respectively. Counselling was
offered in 8% of patients, risk assessment was performed in 5% of patients
and life expectancy was not considered in any patients.
Conclusion: Based on the disappointing percentages identiﬁed, we
implemented a risk assessment template and other simple strategies
aiming to facilitate decisions about the appropriateness of both the per-
formance of PSA tests and referral to secondary care.http://dx.doi.org/10.1016/j.ijsu.2016.08.453
0350: PATIENT SATISFACTION WITH INTRAVESICAL BOTULINUM TOXIN
INJECTION UNDER LOCAL ANAESTHETIC: A SERVICE IMPROVEMENT
PROJECT IN A REGIONAL UNIT
P. Burnell*, T. Page, A. Thorpe, C. Harding. The Freeman Hospital, Newcastle
Upon Tyne, UK.
